Celsius Therapeutics, which has launched with series A capital, has become the latest Third Rock-launched company to be backed by GV.
Celsius Therapeutics, a US-based startup developing treatments for cancer and autoimmune diseases, launched yesterday with $65m of series A financing from investors including GV, a subsidiary of internet technology conglomerate Alphabet.
Venture capital firm Third Rock Ventures led the round, which included managed care provider Heritage Provider Network and Alexandria Venture Investments, the VC arm of real estate investment trust Alexandria Real Estate Equities, as well as investment firm Casdin Capital.
Celsius plans to discover and develop medicines by focusing…
